Full-set task population; distinct model failures mean assessable subsets differ. Source Table 1 is authoritative for this snapshot.
These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.
Release 2026-09-30-e37e3ab1284d · Evidence verified: Not verified
Exact outcomes, predictions, identifiers and evaluator are connected.
Missing or unresolved evidence
Verified: Not verified
Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.
Missing or unresolved evidence
Verified: Not verified
A pinned recipe describes the inputs, environment and resource requirements.
Missing or unresolved evidence
Verified: Not verified
Separate data and exposure records support an independent test.
Missing or unresolved evidence
Verified: Not verified
Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.
No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.
5 evaluations · 20 results. Different protocols are not a single leaderboard.
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: AlphaFold 3 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 7.4 irmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen af3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, iRMSD row, AlphaFold 3 column; Table 1 assessable count |
| Configuration: AlphaFold 3 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 0.88 lddt fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen af3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, LDDT row, AlphaFold 3 column; Table 1 assessable count |
| Configuration: AlphaFold 3 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 24.5 lrmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen af3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, lRMSD row, AlphaFold 3 column; Table 1 assessable count |
| Configuration: AlphaFold 3 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 47.9% success-rate percent · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen af3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, Success rate row, AlphaFold 3 column; Table 1 assessable count |
| Configuration: Boltz-1 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 8.8 irmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen boltz1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, iRMSD row, Boltz-1 column; Table 1 assessable count |
| Configuration: Boltz-1 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 0.84 lddt fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen boltz1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, LDDT row, Boltz-1 column; Table 1 assessable count |
| Configuration: Boltz-1 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 30.7 lrmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen boltz1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, lRMSD row, Boltz-1 column; Table 1 assessable count |
| Configuration: Boltz-1 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 33.5% success-rate percent · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen boltz1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, Success rate row, Boltz-1 column; Table 1 assessable count |
| Configuration: Chai-1 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 10.5 irmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen chai1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, iRMSD row, Chai-1 column; Table 1 assessable count |
| Configuration: Chai-1 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 0.85 lddt fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen chai1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, LDDT row, Chai-1 column; Table 1 assessable count |
| Configuration: Chai-1 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 33.4 lrmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen chai1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, lRMSD row, Chai-1 column; Table 1 assessable count |
| Configuration: Chai-1 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 23.6% success-rate percent · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen chai1 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, Success rate row, Chai-1 column; Table 1 assessable count |
| Configuration: HelixFold 3 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 9.97 irmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen helixfold3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, iRMSD row, HelixFold 3 column; Table 1 assessable count |
| Configuration: HelixFold 3 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 0.84 lddt fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen helixfold3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, LDDT row, HelixFold 3 column; Table 1 assessable count |
| Configuration: HelixFold 3 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 33 lrmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen helixfold3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, lRMSD row, HelixFold 3 column; Table 1 assessable count |
| Configuration: HelixFold 3 — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 28.4% success-rate percent · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen helixfold3 Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, Success rate row, HelixFold 3 column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 8.91 irmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, iRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 0.85 lddt fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, LDDT row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 30.4 lrmsd angstrom · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, lRMSD row, Protenix column; Table 1 assessable count |
| Configuration: Protenix — FoldBench published inference | Protocol: FoldBench antibody-antigen published full-set assessment Dataset: FoldBench antibody-antigen published targets | 34.1% success-rate percent · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcefoldbench antibody antigen protenix Not reported Aggregation: source table mean FoldBench supplementary target coverage and performance · Supplementary Table 3, antibody-antigen block, Success rate row, Protenix column; Table 1 assessable count |
Source checking is not independent reproduction. Release 2026-09-30-e37e3ab1284d.
A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
10 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| attributes.scope structure accuracy; no intervention utility Context-only references | Benchmarking all-atom biomolecular structure prediction with FoldBench No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.scope structure accuracy; no intervention utility Context-only references | FoldBench supplementary target coverage and performance No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.total_targets 172 Context-only references | Benchmarking all-atom biomolecular structure prediction with FoldBench No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.total_targets 172 Context-only references | FoldBench supplementary target coverage and performance No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.version published Supplementary Tables 1–3 Context-only references | Benchmarking all-atom biomolecular structure prediction with FoldBench No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.version published Supplementary Tables 1–3 Context-only references | FoldBench supplementary target coverage and performance No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| description Full-set task population; distinct model failures mean assessable subsets differ. Source Table 1 is authoritative for this snapshot. Context-only references | Benchmarking all-atom biomolecular structure prediction with FoldBench No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| description Full-set task population; distinct model failures mean assessable subsets differ. Source Table 1 is authoritative for this snapshot. Context-only references | FoldBench supplementary target coverage and performance No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| name FoldBench antibody-antigen published targets Context-only references | Benchmarking all-atom biomolecular structure prediction with FoldBench No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| name FoldBench antibody-antigen published targets Context-only references | FoldBench supplementary target coverage and performance No field-specific location recorded Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary Information to 10.1038/s41467-025-67127-3 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
View linked audit checks and correction history
Release 2026-09-30-e37e3ab1284d · Record review: source checked
Stable ID: ucc-research-data-foldbench-antibody-antigen